Clinical Trials on Glutathione Metabolism Anemias in Russian Federation

Total 782 results

GlaxoSmithKline

Completed

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Poliomyelitis

Russian Federation
Hoffmann-La Roche

Completed

A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

Anemia

Russian Federation
Sanofi

Completed

Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus (ATLAS)

Diabetes Mellitus, Type 2

Japan, Russian Federation, China, India, Pakistan, Philippines
Geropharm

Completed

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Diabetes Mellitus | Diabetes Mellitus, Type 1

Russian Federation
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

Sickle Cell Anemia | Pulmonary Hypertension | Cerebrovascular Disease | Chuvash Polycythemia

United States, Russian Federation
Eurasian Association of Therapists

Recruiting

Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease (AURA)

COVID-19 | Hypertension | Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Atrial Fibrillation | PreDiabetes | Ischemic Heart Disease | Chronic Heart Failure | Urolithiasis

Russian Federation
Regeneron Pharmaceuticals

Active, not recruiting

Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy

Generalized Lipodystrophy

United States, Peru, Russian Federation, Turkey
Bial - Portela C S.A.

Completed

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Parkinson's Disease

France, Russian Federation
Sanofi

Completed

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
Geropharm

Completed

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Diabetes | Diabetes Mellitus, Type 1

Russian Federation
SatRx LLC

Completed

Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.

Diabetes Mellitus, Type 2

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Russian Federation
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
Tomsk National Research Medical Center of the Russian...

Completed

Results of Coronary Artery Bypass Grafting in Obese Patients

Obesity | Chronic Ischemic Heart Disease

Russian Federation
FibroGen
Astellas Pharma Inc

Completed

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Anemia | Dialysis

Hong Kong, United States, Singapore, Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Terminated

Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Non-alcoholic Fatty Liver Disease

Russian Federation
Bayer

Active, not recruiting

A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy

Prevention of Vitamin Deficiency During and/or Before Pregnancy

Russian Federation, Kazakhstan, Uzbekistan
Hoffmann-La Roche

Completed

A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.

Anemia

Russian Federation
MEDA Pharma GmbH & Co. KG

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

Diabetic Polyneuropathy

Israel, Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

Type I Diabetes Mellitus

Russian Federation
Novartis Pharmaceuticals

Completed

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Transfusion-dependent Anemia

Egypt, Hungary, Turkey, United States, Bulgaria, Italy, Belgium, Russian Federation, Philippines, France, Malaysia, India, Oman, Panama, Lebanon, Thailand, Tunisia
POLYSAN Scientific & Technological Pharmaceutical...
Atlant Clinical Ltd.

Completed

Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients

Metabolic Acidosis

Russian Federation
National Research Center for Preventive Medicine
The League of Clinical Research, Russia

Completed

Primary Prevention Program (3P)

Primary Prevention of Cardiovascular Disease

Russian Federation
Akrikhin
Russian National Atherosclerosis Society

Completed

Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD (UNISON)

Cardiovascular Diseases | Lipid Metabolism Disorders

Russian Federation
GlaxoSmithKline

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Russian Federation
GlaxoSmithKline

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Russian Federation
Sanofi

Completed

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled (LEGEND)

Type 2 Diabetes Mellitus

Lebanon, Russian Federation, Ukraine
Bayer

Completed

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice (REVITALISE)

Erectile Dysfunction

Korea, Republic of, Saudi Arabia, Singapore, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, Israel, Kyrgyzstan
Genzyme, a Sanofi Company

Completed

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Fabry Disease

France, Poland, United States, Russian Federation, United Kingdom
Genzyme, a Sanofi Company

Completed

Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease

Fabry Disease

France, Poland, United States, Russian Federation, United Kingdom
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Impaired Glucose Tolerance

Russian Federation
Sanofi
Regeneron Pharmaceuticals

Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Hypercholesterolemia

Slovenia, Taiwan, Russian Federation, Canada, Netherlands, Brazil, Denmark, Mexico, Spain, Turkey
Novo Nordisk A/S

Completed

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Russian Federation, Israel, Croatia, Czech Republic, Slovenia
Mannkind Corporation

Completed

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

Diabetes Type 2

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

Type II Diabetes Mellitus

Russian Federation
Alexion

Completed

A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

France, United Kingdom, Norway, Russian Federation, Netherlands, United States
Alisa Apreleva
ALS Centre Moscow

Unknown

Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS

ALS (Amyotrophic Lateral Sclerosis) | Dysphagia | Aspiration Pneumonia | Dyspnea | Breathlessness | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Hypernasality | Dysarthria, Flaccid | Dysarthria, Spastic | Dysarthria, Mixed

Russian Federation, United Kingdom
Novo Nordisk A/S

Completed

Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany, South Africa, Russian Federation, Former Serbia and Montenegro, North Macedonia
Novartis Pharmaceuticals

Completed

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Chronic Iron Overload Due to Transfusion-dependant Anemias

Italy, Austria, Thailand, Spain, Germany, Mexico, Malaysia, Greece, United Kingdom, France, Saudi Arabia, United Arab Emirates, Lebanon, Russian Federation, United States, Argentina
AO GENERIUM

Withdrawn

Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

Hereditary Angioedema

Russian Federation
Sanofi

Completed

Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

United States, Canada, Brazil, Poland, Romania, Russian Federation, Ukraine
Novartis Pharmaceuticals

Terminated

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Hereditary Hemochromatosis

Belgium, France, Russian Federation, Romania, Slovakia, Spain, Switzerland
Novartis Pharmaceuticals

Completed

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)

Homozygous Familial Hypercholesterolemia

Hong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
Hoffmann-La Roche

Completed

A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Anemia

Russian Federation
GlaxoSmithKline

Completed

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Russian Federation
Biocad

Recruiting

Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL) (BLUEBELL)

Spinal Muscular Atrophy (SMA)

Belarus, Russian Federation
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Anemia | Chronic Kidney Disease | Chronic Renal Failure

Russian Federation
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
Charite University, Berlin, Germany
University of Hull; IRCCS San Raffaele; Hannover Medical School; Russian Cardiology... and other collaborators

Completed

Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

Heart Failure | Type 2 Diabetes Mellitus

Germany, Slovenia, United Kingdom, Italy, Poland, Russian Federation

Clinical Trials on Glutathione Metabolism Anemias in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations